Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
Sponsor: Vertex Pharmaceuticals Incorporated
Summary
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
Official title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Evaluating the Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
367
Start Date
2024-10-29
Completion Date
2025-05-27
Last Updated
2026-05-28
Healthy Volunteers
No
Conditions
Interventions
VX-993
Tablets for oral administration.
HB/APAP
Capsules for oral administration.
Placebo (matched to VX-993)
Placebo matched to VX-993 for oral administration.
Placebo (matched to HB/APAP)
Placebo matched to HB/APAP for oral administration.
Locations (14)
Shoals Medical Trials Inc.
Sheffield, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Trovare Clinical Research
Bakersfield, California, United States
New Hope Research Development | Tarzana, CA
Tarzana, California, United States
Clinical Pharmacology of Miami
Miami, Florida, United States
ForCare Clinical Research
Tampa, Florida, United States
Atlanta Center for Medical Research
Atlanta, Georgia, United States
BioBehavioral Research of Austin
Austin, Texas, United States
HD Research LLC | First Surgical Hospital
Bellaire, Texas, United States
HD Research LLC | Legent Orthopedic Hospital
Carrollton, Texas, United States
Memorial Hermann Village
Houston, Texas, United States
Endeavor Clinical Trials
San Antonio, Texas, United States
JBR Clinical Research
Salt Lake City, Utah, United States